Orchid Pharma share news, announcements and annual reports
NSE: ORCHPHARMABSE: 524372Pharmaceuticals & BiotechnologySmall Cap
Orchid Pharma Limited · Formerly Orchid Chemicals & Pharmaceuticals · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Dec 1993 on BSE, Jul 2010 on NSE
Last close ₹836.45down ₹56.95 (6.37%)BSE ₹833.05
Share price at the NSE close on 30 Oct 2026. Previous close ₹893.40.
30 Oct: open ₹893.45, high ₹893.45, low ₹830.00
52-week range of traded prices to 30 Oct 2026
₹480.00Low, 30 Mar 2026₹1,143.50High, 22 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹5,009 Cr919th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 0.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.19
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 88,12456.8% delivered
Orchid Pharma orders, deals and press releases
141 filed, newest first. Page 3 of 3.
Sep 2009
16 Sep · Business
Media release dated September 16, 2009, titled "Orchid's Piperacillin - Tazobactam ANDAs receive US FDA nod Granted 180-days generic drug exclusivity". A copy of the media release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Aug 2009
13 Aug · Business
Media release dated August 13, 2009, titled "Orchid receives Final US FDA nod for Sumatriptan Tablets". A copy of the media release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.12 Aug · Business
Media release dated August 12, 2009, titled "Orchid Chemicals & Pharmaceuticals Ltd (Orchid) and Schering-Plough Corporation (SGP) Settle Clarinex and Clarinex RediTabs Patent Lawsuits". A copy of the media release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2009
31 Jul · Business
Press release dated July 31, 2009 titled "Orchid registers turnover of Rs 309 crore during Q1 FY10". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.3 Jul · Business
Press release dated July 03, 2009 titled "Orchid receives US FDA approval for Amlodipine Besylate Tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jun 2009
29 Jun · Business
Press release dated June 29, 2009, titled " Orchid registers a turnover of Rs. 1211 crore during FY09". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
May 2009
11 May · Business
Media release dated May 11, 2009 titled "Orchid receives Tentative US FDA nod for Sumatriptan Tablets". A copy of the media release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Apr 2009
9 Apr · Business
Press release dated April 09, 2009, titled "Orchid's facility conferred global recognition". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2009
28 Jan · Business
Press release dated January 28, 2009, titled "Orchid registers turnover of Rs.310 crore during Q3 FY09 Maintains operational profitability (PBT) at Rs.28 crore; Earnings for the quarter ended December 31, 2008 (Q3 FY09)". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.16 Jan · Business
Press release dated January 16, 2009, titled "Orchid receives US FDA approval for Levetiracetam Tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Dec 2008
4 Dec · Business
Media release dated December 04, 2008 titled "Orchid receives US FDA approval for Divalproex Sodium DR tablets". A copy of the media release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2008
30 Oct · Business
Press release dated October 30, 2008, titled "Orchid's revenue during Q2FY09 rises by 18.7% to Rs. 348.45 crore; Achieves Salient progress in the Generics and R & D Verticals". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.16 Oct · Business
Press release dated October 16, 2008, titled "Orchid receives US FDA approvals for three Cefuroxime Inj. ANDAs". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Sep 2008
29 Sep · Business
Press release dated September 29, 2008, titled "Orchid & Merck & Co., Inc. collaborate to develop novel anti-infective drugs". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Aug 2008
14 Aug · Business
Press release dated August 13, 2008, titled "Orchid to develop Novel Anticoagulant Drug Candidate from Merck". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.4 Aug · Business
Press release dated August 04, 2008, titled "Orchid receives EU approvals for Piperacillin Tazobactam injection". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2008
30 Jul · Business
Press release dated July 30, 2008, titled "Orchid's Q1 FY09 income grows 30%". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jun 2008
24 Jun · Business
Press release dated June 24, 2008, titled, "Orchid receives Canadian approval for Piperacillin Tazobactam injection". The copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
May 2008
29 May · Business
Press release dated May 29, 2008, titled "Orchid's FY08 turnover rises by 36% to Rs.1239 crore; Net profit records a growth of 91%; Board recommends dividend of 30%". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Apr 2008
22 Apr · Business
Press release dated April 22, 2008, titled "Ranbaxy and Orchid announce strategic business alliance - To leverage respective strengths for mutually beneficial business growth". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.10 Apr · Business
Media release dated April 10, 2008, titled "Orchid announces the formation of its Japanese Subsidiary, Orchid Pharma Japan KK - To drive foray into the growing high potential Japanese generics market". A copy of the media release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Mar 2008
18 Mar · Business
Press Release dated March 18, 2008 titled " Orchid Chemicals clarifies on market fall of its shares". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2008
20 Feb · Business
Press release dated February 20, 2008, titled "Orchid receives US FDA approval for Cefuroxime Axetil ANDA ". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.14 Feb · Business
Press release dated February 14, 2008, titled "Orchid receives USFDA nod for Granisetron generic formulation First Indian company to be approved for this non-antibiotic product". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.8 Feb · Business
Press release dated February 08, 2008, titled "Orchid ropes in Dr Gopalan to head its Drug Discovery initiatives; To head Orchid Research Labs as CSO & Director". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2008
17 Jan · Business
Press release dated January 17, 2008, titled "Orchid's Q3 FY08 revenue up by 39% to Rs 333 crore; Net Profit rises by 91% to Rs. 54 crore". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.11 Jan · Business
Press release dated January 11, 2008, titled "Orchid's formulation facilities receive MCC (South Africa) nod Cephalosporin & Penicillin Injectable facilities approved". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Nov 2007
16 Nov · Business
Press release dated November 16, 2007, titled "Orchid receives US FDA approval for Cefpodoxime Proxetil ANDA". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2007
18 Oct · Business
Press release dated October 18, 2007, titled "Orchid's Q2 FY08 revenue higher by 20% at Rs 295 crore ; Net profit jumps 115% to Rs 63 crore". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2007
30 Jul · Business
Media release dated July 28, 2007, titled "Orchid's Managing Director honoured with Doctorate by leading university". A copy of the media release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.20 Jul · Business
Press release dated July 20, 2007, titled "Orchid receives US FDA approval for its Cefdinir ANDAs". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.19 Jul · Business
Press release dated July 19, 2007, titled "Orchid Q1 FY 2007-08 net profit surges by 252% to Rs 51 crore". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jun 2007
21 Jun · Business
"Orchid has received approval from the US FDA for its ANDA (Abbreviated New Drug Application) for CEfepime injection. The product is available in three dosage strength 500 mg/vial, 1 gram/vial, and 2 grams/vial". A copy of the press release dated June 21, 2007, titled "Orchid receives US FDA approval for its Cefepime ANDA" shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.15 Jun · Business
Press release dated June 15, 2007, titled "Orchid forays into the non-antibiotic generic formulations segment". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
May 2007
3 May · Business
Press release dated May 03, 2007, titled "Orchid's turnover rises to Rs.934 crore during FY 2006-07- Net profit increases to Rs 97 crore". The copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Apr 2007
30 Apr · Business
"Orchid's wholly-owned Drug Discovery subsidiary in Chennai, Orchid Research Laboratories Ltd (ORLL) has been conferred the Frost & Sullivan Award for Partner of Choice in Contract Research - Collaborative Drug Discovery". A copy of the press release issued by the Company dated April 30, 2007, titled "Orchid's drug discovery subsidiary (Orchid Research Labs) awarded Partner of Choice award by Frost & Sullivan" shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.3 Apr · Business
"Orchid has received the approval from the Canadian TPD (Therapeutic Product Directorate) for 2 of its ANDS (Abbreviated New Drug Submission) applications. These approvals correspond to two generic formulations, Cefoxitin and Ceftriaxone". Further the Company has submitted a copy of press release dated April 03, 2007, titled "Orchid to foray into the Canadian generic formulations market". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2007
26 Feb · Business
Press release dated February 25, 2007, titled "Orchid's Zero coupon FCCB issue to retire foreign currency debt and support other business purposes". The copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.1 Feb · Business
Orchid has entered into a licensing and distribution agreement with the international generic pharmaceuticals company Actavis, Iceland for marketing 9 of Orchid's cephalosporin generic formulations in Europe. A copy of press release in this regard dated February 01, 2007, titled Orchid in a new licensing and distribution alliance with Actavis to market cephalosporin formulations in Europe" shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2007
22 Jan · Business
Media release dated January 22,2007, titled "Orchid's Betalactam API facility at Aurangabad approved by the UK MHRA". A copy of the media release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.19 Jan · Business
Press release dated January 19,2007, titled "Orchid registers turnover of Rs 239 crore during Q3 FY 2006-07; Net profit stands at Rs 28 crore". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.